Novoflex: Devising Advanced Sealing Technology That Tackles Pharma Counterfeiting Risks

Dinesh Banka, CEO & Managing Director, Vaibhav Banka & DESCRIPTION Vineet Banka, Directors

Dinesh Banka, CEO & Managing Director

Vaibhav Banka & DESCRIPTION Vineet Banka, Directors

The Indian pharmaceutical sector has emerged as a global leader in generics and specialty medicines. However, with growth accelerating, the industry faces mounting threats with product diversion, counter­feiting, and copying. It not only threatens patient safety but also erodes brand trust and causes significant reve­nue loss.

Furthermore, weak traceability systems and in­sufficient tertiary packaging make product tracking more difficult, often leading to a breakdown in consumer confi­dence. As a result, there is a growing demand for scalable, high-security packaging solutions that can be implement­ed without disrupting existing operations.

Novoflex addresses these challenges with precision-engineered security seals featuring embossed company marks, sequential serial numbers, and advanced tamper-evident features. These solutions enhance traceability, deter counterfeiting, and reduce product diversion.

It believes in offering fast tooling lead times and customization at scale without compromising quality or cost-effectiveness. Today, the company has become a trusted partner for mission-critical anti-counterfeiting programs, and delivering high-performance sealing systems that protect pharmaceutical brands across domestic and export markets.

Precision Sealing for Safe, Compliant Pharma Logistics

With four decades of engineering expertise, Novoflex has garnered a robust reputation for delivering high-precision, high-reliability components to industries where quality is non-negotiable. For instance, its in-depth knowledge of high-performance plastics such as PA6 and PA66 allows it to meet demanding technical requirements for durability, stability, and performance.

In the pharmaceutical sector, Novoflex aligns its operations with IATF 16949 standards and the principles of pharmaceutical quality management systems, ensuring complete compliance and traceability.

The company is also fully compliant with HSSSP (Harmonized Standards for the Storage and Security of Pharmaceuticals), further demonstrating its commitment to safeguarding product integrity throughout the supply chain. It’s fully in-house capabilities, ranging from design and tooling to injection moulding, and provides tight control over quality and delivery timelines, allowing clients to move quickly from concept to deployment.

Novoflex has 40 years of engineering experience and has established a robust reputation for supplying high-precision and high-reliability parts to several different industries

Dinesh Banka, CEO & Managing Director, Vaibhav Banka & DESCRIPTION Vineet Banka, Directors

The company's key strengths include low minimum order quantities with tailored branding and markings, rapid prototyping and delivery to meet urgent project timelines, and designs aligned with HSSSP norms.

“Our customisation capabilities and fast tooling turnaround make us a dependable partner for mission-critical anti-counterfeit initiatives. We are uniquely positioned to offer scalability with consistency”, says Dinesh Banka, CEO & Managing Director, Novoflex.

Novoflex range for pharma includes laser-engraved security seals with individual serial numbers, company logos, and optional QR codes for digital traceability. The portfolio also features single-use tamper-evident cable ties and locks that cannot be reused once opened, and shipment identifiers engineered for bulk drug and export consignments. These components are designed to perform consistently under temperature fluctuations, ensuring the integrity of sensitive cargo during transit.

Partnership Built on Trust & Performance

Novoflex's approach goes beyond simply supplying parts. It delivers end-to-end solutions shaped through close client collaboration, beginning with pilot testing, integrating feedback loops, and aligning with established SOPs. This structured engagement process allows customers to validate performance under real-world conditions before scaling up.

The company has built lasting trust by combining consistent product performance with proactive technical support and a zero-surprise policy on pricing and delivery. More than a vendor, Novoflex acts as a strategic partner, helping clients strengthen their supply chain security. Its success is reflected in long-term relationships founded on transparency, reliability, and responsiveness, qualities essential in the highly regulated and fast-evolving pharmaceutical environment.

In practice, this means that a client facing repeated seal tampering in export consignments could work with Novoflex to develop a custom-embossed, serialised security tie tested under simulated shipping conditions. After fine-tuning the design through pilot batches, the client could roll out the solution across all facilities, significantly reducing diversion incidents.

Future-Ready Seals with Smart Technology

Looking ahead, Novoflex is integrating digital intelligence with its physical protection systems. Developments underway include embedding NFC/RFID technology into seals, enabling real-time verification of authenticity, and creating API-readable serialization systems that allow customers to track products through secure digital platforms.

A dedicated R&D cell is being set up to focus on IoT-based brand protection, supported by staff training on global pharmaceutical compliance standards. This ensures that new solutions meet the highest regulatory benchmarks while staying adaptable to evolving threats.

For example, a future-generation seal could allow a shipment’s status to be scanned at multiple checkpoints without breaking the seal, creating a tamper-proof digital audit trail accessible to both manufacturer and regulator. This would help ensure both product security and compliance with tightening international traceability laws.

Expanding Capabilities across Industries

From its origins as a specialist in electrical wiring accessories, Novoflex has steadily broadened its capabilities. It is now an OEM-approved vendor for automotive leaders such as Maruti, Hyundai, Tata, and TVS, while also supplying to the telecom and solar sectors. The company’s expansion into the pharmaceutical space has been supported by the commissioning of a dedicated pharma-grade injection moulding facility at Chak Barali, Kolkata, complete with clean-room infrastructure.

By combining engineering expertise, compliance-focused processes, and a commitment to innovation, Novoflex is positioning itself as a leader in secure, compliant, and intelligent packaging solutions for the pharmaceutical sector.

on the deck


Most Viewed

Addressing Antimicrobial Resistance (AMR) Through Collaborative Efforts Fostering a Quality Culture in the Pharmaceutical Industry Advancements in Computer-Aided Drug Design for Pharmaceutical Research Why India is Gaining Popularity for Clinical Trials The Future of Kidney Transplants in India Usage of Conversational AI in the Health Insurance Sector Strategies for India to Reduce Its API Dependence on China Business Impact of USFDA Approvals on Indian Pharma Companies Innovative Strategies for Expanding Access to Life Saving Healthcare Solutions Badhal Village Crisis: How Rapid Diagnostics Could Have Saved Lives Why India is a Hotspot for Biotech Startups? Why Adapting Flexibility in IP Rights will Drive Generics Market Meeting the Challenges of High-Potency API (HPAPI) Production Impact of Human Factors Engineering on Medical Device Safety The Future of Pharma: Embracing Continuous Manufacturing The Role of Orphan Drugs in Treating Rare Diseases Emerging Technologies Shaping the Future of Drug Formulation Strategies for Optimizing Pharmaceutical Supply Chain Efficiency The Future of Medicine: Harnessing the Power of RNA-based Therapeutics AI in Medicine: Unmasking the Myths and Embracing the Transformative Reality Cycle Pharma Acquires Banner Life Sciences WHO's First-ever Global Summit on Traditional Medicine Starts in Gujarat The Importance of Data Integrity in Pharmaceutical Quality Control DCGI in Talks with Stakeholders to Develop a Standardised Web Platform to Assure Drug Quality and Patient Safety Glenmark Pharmaceuticals secures ANDA Nod for 0.03 per cent Tacrolimus Ointment Streamlining Laboratory Operations with a Modern LIMS Healthtech Start-up Suraksha QR Ropes In Actor Murali Sharma as its Brand Ambassador Unlocking the Potential of Pharmacogenomics: Enhancing Drug Safety and Efficacy The Impact of Pharmaceutical Testing on Drug Development India has Identified Three Health Priorities to Strengthen Global Health Infrastructure, says WHO National Health Authority launches 100 Microsites Project to Speed Up Digital Health Adoption India Should Partner with Australia to avail PBS for the Selection, Listing, and Pricing processes of exported drugs, says Sudarshan Jain Zydus Lifesciences India More than Doubles Profit Due to Increased Sales in the US India Triples Organ Donations over Past Decade says Union health minister Mansukh Mandaviya Advent Therapeutics Awarded $3 Million NIH Grant For Novel Neonatal Lung Therapy Three Pharma Marketing Strategies That Drive Sales Novartis Targets India's Rare Disease Market with 17 Clinical Programs UK Health Regulator approves GSK's Vaccine for the common respiratory virus RSV WHO Urges Increased Use Of Recommended Malaria-Fighting Tools Karnataka Budget Offered a Significant Boost to Health & Lifesciences Start-ups with Focus on Infrastructure & Innovation Three High Potential Moonshot Project Areas in Pharma CCI approves Bharat Biotech International-Eastman Exports deal How Biotech is Revolutionizing the Fight Against Cancer LifeCell and HaystackAnalytics ink strategic pact to scale-up TB whole genome sequencing pan-India Mankind Pharma IPO To Open On April 25 With A Price Fixed At Rs 1,026-1,080 Per Share US CDC Approves Second Omicron-Updated COVID Booster For Adults Three Trends that will Impact Pharmaceutical Industry in 2023 ModeX Therapeutics Commences Phase I EBV Vaccine Trial with Merck Designing Impactful Leadership and Talent Management Programs with Strategies for Success Novo Nordisk and Valo Health Partner to develop novel Treatments FOPE Calls for Extended Deadline for Schedule M Compliance Telix Pharma To Acquire ImaginAb to Boost Therapeutics and Innovation Roche Secures US FDA Approval for its Ultra-Sensitive ISH test Rappta Therapeutics and SpringWorks Partner on Molecular Glue Targeting PP2A Taro Pharma To Acquire entire stake in Antibe Therapeutics Innovent Biologics Secures Breakthrough Therapy Designation for IBI343 Emcure Pharma Launches Largest R&D Centre in Ahmedabad Zydus Bags USFDA Nod for Phase II(b) Trial to Optimize Usnoflast Dosage US FDA Approves Amgen's Lumakras-Vectibix Combo for KRAS G12C-Mutated mCRC Glenmark Pharma Unveils generic anticoagulant injectable emulsion Strides Pharma Bags USFDA Nod for OTC Acetaminophen-Ibuprofen Combo Tablets US FDA Lifts Hold on Sanofi's Trial to Make Cialis Available Over-the-Counter Hoth Therapeutics Expands Intellectual Property with New Patents Jaguar Health Starts POC Trial of Crofelemer for Rare Pediatric Disease MVID Pharma and Healthcare Sector Eyes Union Budget 2025 for Innovation Boost How Innovative Drug Formulations are Enhancing Treatment Outcomes Apollo and Mayapada Healthcare Unite to Boost Indonesia's Healthcare Novo Nordisk Reports Positive Phase 1b/2a Results for Amycretin Govt to Extend Schedule M Compliance Deadline for Drug Manufacturers to Dec Lupin Secures US FDA Nod for Ipratropium Bromide Nasal Solution ANDA Granules Pharmaceuticals Secures USFDA Nod for Key Generic Drug Bajaj Healthcare Bags DCGI Nod to Manufacture Pimavanserin API & Formulation Union Budget 2025: Healthcare Gets 9.78% Boost, Allocation Nears 1 Lakh Crore Metropolis & Roche Launch Self-Sampling HPV Test for Cervical Cancer Sigachi Industries Invests $1M in Hyderabad R&D Hub for API Innovation Pharma Testing Market Surges with Rising Demand for Biologics ISTH Releases Clinical Practice Guideline For Haemophilia Treatment Sanofi and Biovac Lead Polio Vaccine Manufacturing Capabilities Sun Pharma and Takeda Ink Pact To Market Gastrointestinal Drug Takeda and Ascentage Pharma Ink Option Agreement For Olverembatinib Enhancing Compliance through Effective Pharmaceutical Regulatory Affairs Strategies India poised to become a Global Hub for Clinical Trials: Exec SCHOTT Pharma Unveils Next-Gen Polymer Syringes for Enhanced Safety GSK's Jemperli Gains EU Nod for First-Line Treatment of Endometrial Cancer Union Health Secretary Urges Stronger Drug Regulations for Quality Control Telangana Govt Inks Landmark Deals to Propel Life Sciences and Job Growth R&D in Indian Pharma: Breakthroughs and Innovations in 2024 Dr. Reddy's Partners with Shanghai Henlius to Develop Cancer Drug Uniphar Expands Global Footprint with Three New Facilities 74th Indian Pharmaceutical Congress 2025 Opens Registrations AGC Pharma Expands HPAPI Capabilities in Barcelona to Meet Growing Demand The Future of Genomic Sequencing: Trends That Will Define the Next Decade Lexaria Bioscience Ethics Review Board Nod to Commence New GLP-1 Study Amitabh Kant Urges India to Focus on Innovation at BioAsia 2025 Government Enhances Research & Integration Initiatives in Unani Medicine Blind & Deaf individuals face Major Barriers to access Medicines: Report C-CAMP and PariSante Campus launched Indo-French Life Sciences Hub Jaguar Health Begins Pediatric Trial for Crofelemer in Short Bowel Syndrome Algiax Pharma Reports Promising Phase 2a Results for AP-325 Govt Bans 34 Antimicrobials for Use in Animals Pharmaceutical Procurement Strategies: How to Optimize Costs Personalized Medicine: Get Tailored Treatment Plans for You Now How to Bridge the Healthcare Gap in Emerging Markets with MedTech The Evolution of In-Vitro Diagnostics: Trends and Future Prospects Needle-Free Injection System: A Game Changer in Less Pain Vaccination How Global Capability Centers are Shaping the Future of Biometrics Building a Successful Pharma Brand in India: The Role of Scientific Communication Unlocking India's Innovation Potential in Pharma The Future of Green Chemistry in API Production Top 10 Pharmaceutical Recruitment Consultants - 2024 | Pharma Outlook Blockchain for Secure Pharmaceutical Supply Chains - 2025 & Beyond Mass Spectrometry in Biomarker Discovery for Early Disease Detection Iconovo and Lonza Team up to Advance Intranasal Biologic with ICOone Nasal Fetal Imaging to Cardiac Diagnosis: The Expanding Role of Ultrasound Balancing Innovation and Affordability in Medical Solutions for India Changing Landscape for LTBI and Syndromic Testing Methodologies How Advanced Training Methods can Enhance Patient Care Balancing Cost Efficiency and Compliance in Pharmaceutical Manufacturing LUB Urges Govt to Scrap Mandatory Lab Testing for Cough Syrup Exports Role of Optical Imaging in Early Cancer Detection and Treatment Hoth Therapeutics Unveils Promising Data for KIT-Targeting Therapy Pharmexcil Engages ASEAN Nations to Boost Pharma Trade Ties Fortis Partners with Teleflex for South Asia UroLift Training Anti-Infectives: How New Research is Shaping Infection Control Building Bridges for Sustainable Growth through Strategic Alliances in Ethical Pharmaceuticals Quality as the Cornerstone of Lab Solutions FDA Approves Roch's NSCLC Diagnostic Linked to Emrelis How Early Detection is Transforming Cancer Treatment in India Ensuring Data Privacy in Pharma World Enhancing Clinical Trial Supply Chain Resilience to Address Global Disruptions in India Cost-Effectiveness of Minimally Invasive Surgery in Outpatient Settings How Organic Synthesis is Accelerating Drug Discovery in Pharma Strategic finance for pharmaceutical innovation and stability Top 10 Teleradiology Service Providers - 2024 | Pharma Outlook Importance of Investing in R&D and Quality for Competitive Advantage in Eye Care Top 10 In Vitro Diagnostics Companies - 2024 | Pharma Outlook Phytopharmaceuticals: Driving Global Herbal Medicine Innovation Gender Gap in Healthcare: Why Women's Health Needs More Research Impact of Modern Technology on the Indian Life Sciences Sector Why Global Pharma Expects CDMOs to Be Ready for Joint Inspections The Role of Customizable Stent Grafts for Treating Complex Anatomies Nutraceuticals vs Pharmaceuticals: Complementary or Alternative in Chronic Disease Management? Top 10 Pharma CDMO Companies In India – 2023 | Pharma Outlook Leaping Towards Global Compliance with Revised Schedule M Meril Concludes TechVentory, Boosts AI-Driven Healthcare Supply Chains 10 Pharma Sector Revolutions in India Standardizing Medicine Labeling and Embracing Digital Transformation Creating a patient-centric healthcare ecosystem for all Biomanufacturing of Enzymes: A Sustainable Approach to Industrial Biotechnology Integrating CSR into HR Practices to Enhance Brand Reputation in Pharma Merck Launches Phase 3 Trial for Promising Dengue Vaccine V181 Breakthrough: Eye-Opening Healthcare Strategies Doctors Swear By on Doctor's Day 2025 Bristol Myers Squibb Reports Strong Phase 3 Results for Deucravacitinib trail Alcon Launches Innovative Daily Lenses Designed for Long-lasting Comfort Apisolex Excipient by Lubrizol Backs Phase I Drug Success FDA Approves Enflonsia to Prevent RSV in Infants with One Dose Biosimilars in India 2025 Market Trends, Growth Forecast & Opportunities How Regulations Are Shaping India's Medical Device Landscape Bharat Biotech Partners with GSK for Shigella Vaccine Development Eli Lilly Obesity Drug Shows 11.5% Weight Loss in 12 Weeks Laborate Pharmaceuticals: Illuminating Pathways Of Quality, Affordability Innovation In Healthcare Sun Pharma Bags CDSCO Approval to Produce Fexuprazan Hydrochloride Tablets The Fusion of Biology, Medicine, Health, and AI Glenmark Gets DCGI Nod to Launch Oncology Drug BRUKINSA in India Kyndryl Partners with Dr Reddys to Automate Global IT Operations How Robotic Assisted Surgery Is Redefining Precision in Kidney Transplants Top 10 Women Disruptors in Asia Pharmaceutical Industry

Editor's Guest


© 2025 India Pharma Outlook. All Rights Reserved.